Additionally, we found that concomitant GLP-1RA/SGLT-2i prescription trended toward improved 60-day mortality when compared to GLP-1RA or SGLT2i monotherapy but did not reach statistical significance.
← all excerpts
Association of Premorbid GLP-1RA and SGLT-2i Prescription Alone and in Combination with COVID-19 Severity.
1
—
—